Exelon Corp. (NYSE: EXC) reported Q2 EPS of $0.65, $0.09 better than the analyst estimate of $0.56. Revenue for the quarter came in at $6.9 billion versus the consensus estimate of $7.3 billion.

GUIDANCE:

Exelon Corp. sees Q3 2016 EPS of $0.65-$0.75, versus the consensus of $0.80.

Exelon Corp. sees FY2016 EPS of $2.40-$2.70, versus the consensus of $2.53.

For earnings history and earnings-related data on Exelon Corp. (EXC) click here.